Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Zydus Pharmaceuticals USA Inc.

NDC labeler codes: 68382, 70710

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

621Products (NDC)

Prescription medicines

Show the other 158 medicines

FDA applications for these products

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
ApprovedApplicationMedicineSponsor
October 19, 2026ANDA220407 Estradiol and levonorgestrel
ESTRADIOL AND LEVONORGESTREL
Zydus Pharms
August 20, 2026ANDA220873 Ascorbic acid
ASCORBIC ACID
Zydus Pharms
July 21, 2026ANDA220447 Fluvoxamine maleate
FLUVOXAMINE MALEATE
Zydus Pharms
June 11, 2026ANDA219287 Gadobutrol
GADOBUTROL
Viwit Pharm
June 1, 2026ANDA218651 Fluorescein (fluorescein sodium)
FLUORESCEIN SODIUM
Zydus Lifesciences
May 7, 2026ANDA217191 Hydrocortisone
HYDROCORTISONE SODIUM SUCCINATE
Zydus Pharms
April 23, 2026ANDA220568 Glycerol phenylbutyrate
GLYCEROL PHENYLBUTYRATE
Navinta LLC
April 6, 2026ANDA211582 Dapagliflozin
DAPAGLIFLOZIN
Zydus Pharms
March 4, 2026ANDA215864 Calcitonin salmon
CALCITONIN-SALMON
Zydus Pharms
February 17, 2026ANDA213981 Bosentan
BOSENTAN
Zydus Pharms
February 17, 2026ANDA220418 Sodium phenylbutyrate
SODIUM PHENYLBUTYRATE
Navinta LLC
January 29, 2026ANDA220275 Sertraline hydrochloride
SERTRALINE HYDROCHLORIDE
Zydus Lifesciences
January 14, 2026ANDA216281 Eltrombopag
ELTROMBOPAG OLAMINE
Zydus Pharms
December 18, 2025BLA761473 Ranibizumab-eqrn
NUFYMCO
Formycon AG
November 24, 2025ANDA219252 Verapamil hydrochloride
VERAPAMIL HYDROCHLORIDE
Zydus Lifesciences
November 14, 2025ANDA217468 Diazepam
DIAZEPAM
Navinta LLC
October 27, 2025ANDA219931 Sevelamer carbonate
SEVELAMER CARBONATE
Navinta LLC
October 3, 2025ANDA220042 Deflazacort
DEFLAZACORT
Zydus Lifesciences
May 22, 2025ANDA216633 Isotretinoin
ISOTRETINOIN
Zydus Pharms
May 13, 2025ANDA217880 Maraviroc
MARAVIROC
Navinta LLC
May 7, 2025ANDA208468 Glatiramer acetate
GLATIRAMER ACETATE
Chemi Spa
April 8, 2025ANDA219254 Deflazacort
JAYTHARI
Zydus Lifesciences
March 14, 2025ANDA219111 Miglustat
MIGLUSTAT
Navinta LLC
March 3, 2025ANDA218719 Dasatinib
DASATINIB
Zydus Pharms
February 3, 2025ANDA218966 Sevelamer hydrochloride
SEVELAMER HYDROCHLORIDE
Navinta LLC
Show the other 100 applications
ApprovedApplicationMedicineSponsor
October 23, 2024NDA218711 Docetaxel
BEIZRAY
Zhuhai
August 29, 2024ANDA217893 Scopolamine
SCOPOLAMINE
Zydus Pharms
July 18, 2024NDA216778 Sitagliptin and metformin hydrochloride
ZITUVIMET XR
Zydus Lifesciences
July 9, 2024ANDA213719 Sacubitril and valsartan
SACUBITRIL AND VALSARTAN
Zydus Pharms
March 13, 2024ANDA217275 Chlorpromazine hydrochloride
CHLORPROMAZINE HYDROCHLORIDE
Zydus Pharms
January 24, 2024ANDA203934 Gabapentin
GABAPENTIN
Zydus Pharms
December 5, 2023ANDA215636 Methylene blue
METHYLENE BLUE
Zydus Lifesciences
November 29, 2023ANDA213442 Ivabradine
IVABRADINE HYDROCHLORIDE
Zydus Pharms
November 3, 2023NDA216743 Sitagliptin and metformin hydrochloride
ZITUVIMET
Zydus Lifesciences
October 18, 2023NDA211566 Sitagliptin
ZITUVIO
Zydus Lifesciences
October 4, 2023ANDA214290 Sugammadex
SUGAMMADEX SODIUM
Zydus Pharms
September 14, 2023ANDA214594 Norelgestromin and ethinyl estradiol
ETHINYL ESTRADIOL AND NORELGESTROMIN
Zydus Pharms
August 29, 2023ANDA211568 Isotretinoin
ISOTRETINOIN
Zydus Pharms
August 22, 2023ANDA217074 Zinc sulfate
ZINC SULFATE
Zydus Pharms
August 2, 2023ANDA216184 Indomethacin
INDOMETHACIN
Zydus Lifesciences
July 26, 2023ANDA208980 Plerixafor
PLERIXAFOR
Zydus Pharms
July 14, 2023ANDA217526 Sodium phenylacetate and sodium benzoate
SODIUM PHENYLACETATE AND SODIUM BENZOATE
Navinta LLC
July 3, 2023ANDA211747 Oxcarbazepine
OXCARBAZEPINE
Zydus
June 12, 2023ANDA216723 Varenicline tartrate
VARENICLINE TARTRATE
Zydus
June 8, 2023ANDA217592 Balsalazide disodium
BALSALAZIDE DISODIUM
Zydus Lifesciences
June 7, 2023ANDA206055 Esomeprazole
ESOMEPRAZOLE MAGNESIUM
Zydus Pharms
April 20, 2023ANDA217656 Icosapent ethyl
ICOSAPENT ETHYL
Zydus Lifesciences
April 17, 2023ANDA204379 Estradiol
ESTRADIOL
Zydus Pharms
April 4, 2023ANDA211069 Acetazolamide
ACETAZOLAMIDE
Zydus Lifesciences
March 29, 2023ANDA202985 Estradiol
ESTRADIOL
Zydus Pharms
March 24, 2023ANDA217066 Levothyroxine
LEVOTHYROXINE SODIUM
Zydus Pharms
March 23, 2023ANDA214131 Lubiprostone
LUBIPROSTONE
Zydus Pharms
March 14, 2023ANDA209829 Tofacitinib
TOFACITINIB CITRATE
Zydus Pharms
March 7, 2023ANDA212693 Erythromycin
ERYTHROMYCIN
Zydus Lifesciences
March 2, 2023ANDA214671 Vigabatrin
VIGABATRIN
Zydus Lifesciences
February 22, 2023ANDA206047 Pitavastatin
PITAVASTATIN CALCIUM
Zydus Pharms
December 28, 2022ANDA213003 Triazolam
TRIAZOLAM
Zydus Pharms
December 21, 2022ANDA214302 Selexipag
SELEXIPAG
Zydus Lifesciences
December 1, 2022ANDA206241 Estradiol
ESTRADIOL
Zydus Pharms
November 28, 2022ANDA208949 Topiramate
TOPIRAMATE
Zydus
October 24, 2022ANDA215241 Micafungin
MICAFUNGIN SODIUM
Zydus Pharms
October 21, 2022ANDA217038 Ketorolac tromethamine
KETOROLAC TROMETHAMINE
Zydus Lifesciences
October 3, 2022ANDA214501 Brivaracetam
BRIVARACETAM
Zydus Pharms
September 29, 2022ANDA209488 Mirabegron
MIRABEGRON
Zydus Pharms
September 29, 2022ANDA215708 Sildenafil
SILDENAFIL CITRATE
Zydus Lifesciences
September 12, 2022ANDA210154 Lenalidomide
LENALIDOMIDE
Zydus Pharms
September 1, 2022ANDA211135 Riociguat
RIOCIGUAT
Msn
August 30, 2022ANDA215622 Venlafaxine
VENLAFAXINE HYDROCHLORIDE
Zydus Pharms
August 8, 2022ANDA216495 Prochlorperazine
PROCHLORPERAZINE MALEATE
Zydus Lifesciences
June 29, 2022ANDA209465 Lacosamide
LACOSAMIDE
Zydus Pharms
June 3, 2022ANDA216441 Famotidine
FAMOTIDINE
Zydus Pharms
May 11, 2022ANDA215750 Diclofenac
DICLOFENAC POTASSIUM
Umedica
May 2, 2022ANDA210204 Bortezomib
BORTEZOMIB
Zydus Pharms
April 15, 2022ANDA214655 Cyanocobalamin
CYANOCOBALAMIN
Zydus Pharms
March 10, 2022ANDA215223 Colestipol hydrochloride
COLESTIPOL HYDROCHLORIDE
Zydus Pharms
February 10, 2022ANDA208303 Roflumilast
ROFLUMILAST
Zydus Pharms
January 19, 2022ANDA215707 Vigabatrin
VIGABATRIN
Zydus Lifesciences
November 17, 2021ANDA215037 Nelarabine
NELARABINE
Zydus Pharms
August 19, 2021ANDA214264 Tofacitinib
TOFACITINIB CITRATE
Zydus Pharms
August 12, 2021ANDA208954 Mesalamine
MESALAMINE
Zydus Pharms
July 29, 2021ANDA215234 Fulvestrant
FULVESTRANT
Zydus Pharms
May 27, 2021ANDA214552 Fluphenazine hydrochloride
FLUPHENAZINE HYDROCHLORIDE
Zydus Lifesciences
April 21, 2021ANDA214184 Propafenone hydrochloride
PROPAFENONE HYDROCHLORIDE
Zydus Lifesciences
April 6, 2021ANDA211224 Macitentan
MACITENTAN
Zydus Lifesciences
February 24, 2021ANDA213441 Nortriptyline hydrochloride
NORTRIPTYLINE HYDROCHLORIDE
Zydus Lifesciences
February 18, 2021ANDA211818 Droxidopa
DROXIDOPA
Zydus Pharms
January 22, 2021ANDA214803 Liothyronine sodium
LIOTHYRONINE SODIUM
Zydus Lifesciences
October 22, 2020ANDA208884 Albuterol sulfate
ALBUTEROL SULFATE
Zydus Pharms
October 16, 2020ANDA214295 Ursodiol
URSODIOL
Zydus Lifesciences
October 15, 2020ANDA214215 Verapamil hydrochloride
VERAPAMIL HYDROCHLORIDE
Zydus Pharms
October 14, 2020ANDA207994 Fingolimod
FINGOLIMOD HYDROCHLORIDE
Zydus Pharms
September 24, 2020ANDA210538 Dimethyl fumarate
DIMETHYL FUMARATE
Zydus Pharms
September 17, 2020ANDA210395 Potassium chloride
POTASSIUM CHLORIDE
Zydus Pharms
September 10, 2020ANDA212299 Doxorubicin hydrochloride
DOXORUBICIN HYDROCHLORIDE (LIPOSOMAL)
Zydus Lifesciences
September 1, 2020ANDA213055 Midodrine hydrochloride
MIDODRINE HYDROCHLORIDE
Zydus Lifesciences
August 11, 2020ANDA207759 Sevelamer carbonate
SEVELAMER CARBONATE
Zydus Pharms
June 23, 2020ANDA213957 Meclizine hydrochloride
MECLIZINE HYDROCHLORIDE
Zydus Lifesciences
April 16, 2020ANDA213065 Erlotinib
ERLOTINIB HYDROCHLORIDE
Zydus Pharms
April 6, 2020ANDA205232 Perphenazine
PERPHENAZINE
Zydus Pharms
April 1, 2020ANDA207763 Lamotrigine
LAMOTRIGINE
Zydus Pharms
February 28, 2020ANDA212689 Emtricitabine and tenofovir disoproxil fumarate
EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE
Zydus Pharms
February 12, 2020ANDA208953 Mesalamine
MESALAMINE
Zydus Pharms
January 17, 2020ANDA213368 Chlorpromazine hydrochloride
CHLORPROMAZINE HYDROCHLORIDE
Zydus Lifesciences
November 20, 2019ANDA211383 Deferasirox
DEFERASIROX
Zydus Pharms
November 20, 2019ANDA213057 Isosorbide dinitrate
ISOSORBIDE DINITRATE
Zydus Lifesciences
November 4, 2019ANDA212171 Cisatracurium besylate
CISATRACURIUM BESYLATE
Zydus Pharms
October 22, 2019ANDA211180 Haloperidol decanoate
HALOPERIDOL DECANOATE
Zydus Pharms
October 7, 2019ANDA207765 Colesevelam hydrochloride
COLESEVELAM HYDROCHLORIDE
Zydus Pharms
July 22, 2019ANDA211567 Ramelteon
RAMELTEON
Zydus Pharms
May 22, 2019ANDA206296 Esomeprazole
ESOMEPRAZOLE MAGNESIUM
Zydus Pharms
May 10, 2019ANDA207813 Chlorthalidone
CHLORTHALIDONE
Zydus Pharms
April 26, 2019ANDA207760 Bosentan
BOSENTAN
Zydus Pharms
April 24, 2019ANDA212308 Leflunomide
LEFLUNOMIDE
Zydus Lifesciences
March 28, 2019ANDA210058 Ambrisentan
AMBRISENTAN
Zydus Pharms
March 26, 2019ANDA206693 Tadalafil
TADALAFIL
Zydus Pharms
March 19, 2019ANDA208052 Lurasidone hydrochloride
LURASIDONE HYDROCHLORIDE
Zydus Pharms
March 11, 2019ANDA208445 Potassium chloride
POTASSIUM CHLORIDE
Zydus Pharms
March 8, 2019ANDA210028 Atenolol and chlorthalidone
ATENOLOL AND CHLORTHALIDONE
Zydus Pharms
March 4, 2019ANDA206318 Rivastigmine
RIVASTIGMINE
Zydus Pharms
February 20, 2019ANDA210189 Phytonadione
PHYTONADIONE
Zydus Lifesciences
February 19, 2019ANDA211519 Colchicine (colchiceine)
COLCHICINE
Zydus Pharms
February 11, 2019ANDA208358 Triamterene and hydrochlorothiazide
TRIAMTERENE AND HYDROCHLOROTHIAZIDE
Cadila
February 7, 2019ANDA205571 Carbamazepine
CARBAMAZEPINE
Zydus Pharms
January 16, 2019ANDA205301 Acetazolamide
ACETAZOLAMIDE
Cadila
January 11, 2019ANDA208885 Betamethasone dipropionate
BETAMETHASONE DIPROPIONATE
Zydus Pharms

Showing the 125 newest of 237 applications. Full lists: Drugs@FDA →

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2026

  1. October 1, 2026 · Class II · Ongoing · D-0039-2027 · Hydrocortisone

    Failed Impurities/Degradation Specifications.

    Hydrocortisone Sodium Succinate for Injection, USP 100 mg/vial, 1 Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara - 391510 India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534,

  2. August 5, 2026 · Class II · Ongoing · D-0745-2026 · Mirabegron

    CGMP: Due to Out of Specification (OOS) result for N-Nitroso Mirabegron impurity.

    Mirabegron Extended-Release Tablets, 25 mg, 30-count bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Matoda, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-

  3. April 29, 2026 · Class II · Ongoing · D-0544-2026 · Erythromycin

    CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit

    Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; a) 30 count bottles (

  4. April 29, 2026 · Class II · Ongoing · D-0545-2026 · Erythromycin

    CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit

    Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; (NDC 70710-1048-3).

  5. March 9, 2026 · Class II · Ongoing · D-0400-2026 · Icosapent ethyl

    Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

    Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1592-7

2025

  1. December 19, 2025 · Class III · Ongoing · D-0247-2026 · Trazodone hydrochloride

    Failed Tablet/Capsule Specifications: Product complaint received that some tablets had a dent on the plain side of the tablet surface.

    traZODONE Hydrochloride Tablets, USP, 100mg, 1,000 Tablets, Rx only, Manufactured by: Zydus Lifesciences Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-806-10

  2. October 23, 2025 · Class II · Ongoing · D-0159-2026 · Bromocriptine mesylate

    Failed Impurities/Degradation Specifications: Out of Specification (OOS) result reported for 2- Bromoergine impurity of Bromocriptine Mesylate Capsules.

    Bromocriptine Mesylate Capsules, USP, 5 mg, 30 Capsules per bottle, Rx Only. Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals, Pennington, NJ 08534. NDC 68382-110-06

  3. September 24, 2025 · Class II · Ongoing · D-0001-2026 · Entecavir

    Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

    Entecavir Tablets, USP, 0.5 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

  4. September 24, 2025 · Class II · Ongoing · D-0002-2026 · Entecavir

    Failed impurity/degradation specifications:Out of Specification result for an individual organic impurity

    Entecavir Tablets, USP, 1 mg, 30-count bottle, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.

  5. September 4, 2025 · Class II · Ongoing · D-0657-2025 · Entecavir

    Failed Impurity/Degradation Specifications

    Entecavir Tablets, USP, 1 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-921-06.

Show the 50 older recalls

2025

  1. September 4, 2025 · Class II · Ongoing · D-0656-2025 · Entecavir

    Failed Impurity/Degradation Specifications

    Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

  2. September 3, 2025 · Class II · Ongoing · D-0636-2025 · Chlorpromazine hydrochloride

    CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

    Chlorpromazine Hydrochloride Tablets, USP, 100 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-113

  3. September 3, 2025 · Class II · Ongoing · D-0630-2025 · Chlorpromazine hydrochloride

    CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

    Chlorpromazine Hydrochloride Tablets, USP, 10 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1129

  4. September 3, 2025 · Class II · Ongoing · D-0634-2025 · Chlorpromazine hydrochloride

    CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

    Chlorpromazine Hydrochloride Tablets, USP, 50 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1131

  5. September 3, 2025 · Class II · Ongoing · D-0632-2025 · Chlorpromazine hydrochloride

    CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

    Chlorpromazine Hydrochloride Tablets, USP, 25 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1130

  6. September 3, 2025 · Class II · Ongoing · D-0638-2025 · Chlorpromazine hydrochloride

    CGMP Deviations: presence of N-Nitroso Desmethyl Chlorpromazine above the recommended acceptable intake limit

    Chlorpromazine Hydrochloride Tablets, USP, 200 mg, 100-count bottle, Rx only, Manufactured By: Zydus Lifesciences Ltd., Baddi, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-113

  7. August 27, 2025 · Class II · Ongoing · D-0623-2025 · Succinylcholine

    Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation impurity.

    Succinylcholine Chloride Injection, USP 200 mg/10 mL (20 mg/mL), Rx only, 10 mL Multiple-dose Vial, Sterile, Manufactured by Zydus Lifesciences Ltd, Vadodara, India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Penn

  8. May 30, 2025 · Class II · Completed · D-0497-2025 · Icosapent ethyl

    Failed Tablet/Capsule specifications; a product complaint was reported for burnt or melted capsules. This was determined to be a result of oxidation by leakage of capsule contents.

    Icosapent Ethyl Capsules 1 gram, 120 Capsules per Bottle, Rx Only, Manufactured by Doppel Farmaceutici s.r.l., Piacenza, Italy, Distributed by Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1592-7.

  9. May 13, 2025 · Class II · Ongoing · D-0442-2025 · Esomeprazole

    Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.

    Esomeprazole Magnesium for Delayed-Release Oral Suspension, 40 mg, 30-count Single-Dose Packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA)

  10. May 13, 2025 · Class II · Ongoing · D-0443-2025 · Esomeprazole

    Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.

    Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA)

  11. April 3, 2025 · Class II · Ongoing · D-0361-2025 · Chlorpromazine hydrochloride

    CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit

    chlorproMAZINE Hydrochloride Tablets, USP 10 mg, Rx Only, 100 Tablets bottles, Manufactured by: Zydus Lifesciences Ltd., Baddi, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-112

  12. March 21, 2025 · Class II · Completed · D-0310-2025 · Venlafaxine

    Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.

    Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01.

  13. February 13, 2025 · Class II · Ongoing · D-0256-2025 · Nelarabine

    Failed Impurities/Degradation Specifications

    Nelarabine Injection, 250mg/50mL, (5mg/mL), packaged in: a) 50 mL Single-Dose Vial, NDC 70710-1839-1; b) 6 x 50 mL Single-Dose Vial, NDC 70710-1839-8, Rx only, Manufactured by Zydus Lifesciences Ltd, Ahmedabad, India, Di

  14. February 13, 2025 · Class II · Ongoing · D-0255-2025 · Nelarabine

    Failed Impurities/Degradation Specifications

    Nelarabine Injection, 250mg/50mL, (5mg/mL), packaged in: a) 50 mL Single-Dose Vial, NDC 70710-1726-1; b) 6 x 50 mL Single-Dose Vial, NDC 70710-1726-8, Rx only, Manufactured by Zydus Lifesciences Ltd, Ahmedabad, India, Di

2024

  1. November 14, 2024 · Class III · Ongoing · D-0102-2025 · Esomeprazole

    Labeling: Not Elsewhere Classified - Wrong NDC number

    Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg, 30 Single-Dose Packets, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington,

  2. July 2, 2024 · Class III · Ongoing · D-0593-2024 · Verapamil hydrochloride

    Cross contamination with other products.

    Verapamil Hydrochloride Injection, USP 10 mg/4 mL (2.5 mg/mL), 5 x 4 mL Single-Dose Vial per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA)Inc., Pen

  3. July 2, 2024 · Class III · Ongoing · D-0592-2024 · Verapamil hydrochloride

    Cross contamination with other products.

    Verapamil Hydrochloride Injection, USP 5 mg / 2mL(2.5 mg/mL), packaged as (a) 25x2 mL Single-Dose Vial per carton, Vial NDC: 70710-1643-1; Carton NDC 70710-1643-7; (b) 5x2 mL Single-Dose Vial per carton, Vial NDC: 70710-

  4. June 21, 2024 · Class II · Terminated · D-0617-2024 · Venlafaxine

    Failed Dissolution Specifications: Out-of-specification results observed for dissolution testing at the 8-hour and 12-hour pull intervals.

    Venlafaxine Hydrochloride Extended-Release Capsules, USP 37.5mg, packaged in a) 90-count bottles (NDC 68382-034-16) and b)1000-count bottles (NDC 68382-034-10), Rx only, Mfg. by: Zydus Lifesciences Ltd. Ahmedabad, India;

  5. May 16, 2024 · Class III · Ongoing · D-0543-2024 · Estradiol

    Failed Impurities/Degradation Specifications.

    Estradiol Transdermal System, USP (Twice-Weekly) 0.025mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1191-

  6. May 16, 2024 · Class III · Ongoing · D-0542-2024 · Estradiol

    Failed Impurities/Degradation Specifications.

    Estradiol Transdermal System, USP (Twice-Weekly) 0.0375mg/day, Rx Only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1192

2023

  1. October 19, 2023 · Class II · Completed · D-0097-2024 · Oxybutynin

    Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.

    Oxybutynin Chloride Extended-Release Tablet USP, 10 mg, 100 count bottles Rx Only, Manufactured by: Cadila Healthcare Ltd, Baddi, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. NDC # 68382-256-01.

  2. October 19, 2023 · Class II · Completed · D-0098-2024 · Oxybutynin

    Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.

    Oxybutynin Chloride Extended-Release Tablet USP, 15 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Baddi, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. NDC # 68382-257-01.

  3. October 19, 2023 · Class II · Completed · D-0096-2024 · Oxybutynin

    Failed Dissolution Specifications-out-of-specification (OOS) test results observed for dissolution at the 6 month long term time point.

    Oxybutynin Chloride Extended-Release Tablet USP, 5 mg, 100 count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Baddi, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. NDC # 68382-255-01

  4. September 21, 2023 · Class II · Terminated · D-0038-2024 · Oxybutynin

    Failed Dissolution Specifications

    Oxybutynin Chloride Extended-Release Tablets USP 10 mg, a) 100 tablets (NDC 68382-256-01) and b) 500 tablets (NDC 68382-256-05) bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India, Distributed by:

2022

  1. July 15, 2022 · Class II · Terminated · D-1351-2022 · Fulvestrant

    Failed Impurities/Degradation Specifications

    Fulvestrant Injection 250mg/5mL (50 mg/mL), Contains 2 Single-Dose Prefilled Syringes, Rx Only, Product of India, Manufactured by: Cadila Healthcare Limited, Ahmadabad, India, Distributed by: Zydus Pharmaceuticals (USA )

2021

  1. August 13, 2021 · Class II · Terminated · D-0753-2021 · Carvedilol

    Presence of Foreign Tablets/Capsules; report of two Paroxetine tablets were found in the bottle

    Carvedilol Tablets, USP 25 mg, 500 Tablets bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd., India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 0853, NDC 68382-095-05

  2. February 18, 2021 · Class I · Terminated · D-0315-2021 · Acyclovir

    Crystallization: customer complaints for crystallization in finished product.

    Acyclovir Sodium Injection 1000mg/20mL (50mg/mL) vial NDC 68382-049-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 20mL Single-Dose Vials per pack NDC 68382-049-10, Rx only, Manufactured

  3. February 18, 2021 · Class I · Terminated · D-0316-2021 · Acyclovir

    Crystallization: customer complaints for crystallization in finished product.

    Acyclovir Sodium Injection 500mg/10mL (50mg/mL) vial NDC 68382-048-01, For Intravenous Infusion Only MUST BE DILUTED PRIOR TO USE, packaged in 10 x 10mL Single-Dose Vials per pack NDC 68382-048-10, Rx only, Manufactured

2020

  1. December 3, 2020 · Class II · Terminated · D-0146-2021 · Lansoprazole

    Failed Dissolution Specifications

    Lansoprazole Delayed-Release Orally Disintegrating Tablets, 30 mg, 100 Tablets (10 x 10 unit-dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA

  2. December 3, 2020 · Class II · Terminated · D-0145-2021 · Lansoprazole

    Failed Dissolution Specifications

    Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100 Tablets (10x10 unit dose) blister pack, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA In

  3. October 27, 2020 · Class II · Terminated · D-0074-2021 · Lansoprazole

    Failed Dissolution Specification

    Lansoprazole Delayed-Release Orally Disintegrating Tablets 15 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pen

  4. October 27, 2020 · Class II · Terminated · D-0075-2021 · Lansoprazole

    Failed Dissolution Specification

    Lansoprazole Delayed-Release Orally Disintegrating Tablets 30 mg, 100-count carton (10 x10 unit-dose), Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals USA Inc. Pen

2019

  1. May 6, 2019 · Class II · Terminated · D-1441-2019 · Anastrozole

    CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

    Anastrozole Tablets, USP, 1 mg, 1,000-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534. NDC 68382-209-10

  2. May 6, 2019 · Class II · Terminated · D-1440-2019 · Anastrozole

    CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

    ANASTROZOLE Tablets, 1 mg, Rx Only, 30-count bottle, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ 08534 NDC 68382-209-06

  3. May 6, 2019 · Class II · Terminated · D-1453-2019 · Methylprednisolone

    CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

    MethylPREDNISolone Tablets, USP 8 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-917-11

  4. May 6, 2019 · Class II · Terminated · D-1451-2019 · Methylprednisolone

    CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

    MethylPREDNISolone Tablets, USP 32 mg, 25 tablets, Rx Only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-919-11

  5. May 6, 2019 · Class II · Terminated · D-1448-2019 · Methylprednisolone

    CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

    MethylPREDNISolone Tablets, USP, 4 mg, 100 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd Ahmedabad, India NDC 68382-916-01

  6. May 6, 2019 · Class II · Terminated · D-1450-2019 · Methylprednisolone

    CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

    MethylPREDNISolone Tablets, USP 16 mg, 50 tablets, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India NDC 68382-918-18

  7. May 6, 2019 · Class II · Terminated · D-1449-2019 · Methylprednisolone

    CGMP Deviations: Cross Contamination with other products due to CGMP cleaning failure.

    MethylPREDNISolone Tablets, USP 4 mg per tablet, 21 Tablets dosepack, Rx Only, Made in India Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC 68382-916-34

  8. April 25, 2019 · Class II · Terminated · D-1273-2019 · Carvedilol

    Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg

    Carvedilol Tablets, USP, 6.25 mg, 500 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ USA 08534 NDC 68382-093-05

  9. April 25, 2019 · Class II · Terminated · D-1272-2019 · Acyclovir

    Labeling; Label Mix-up; report received of one bottle labeled as Acyclovir Tablets USP 400 mg actually contained Carvedilol Tablets 6.25 mg

    Acyclovir Tablets, USP, 400 mg, 100 count bottles, Rx Only Manufactured by: Cadila Healthcare Ltd., India Distributed by: Zydus Pharmaceuticals (USA) Inc. Pennington, NJ USA 08534 NDC 68382-791-01

  10. April 22, 2019 · Class III · Terminated · D-1242-2019 · Carvedilol

    Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.

    Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; NDC 68382-092-05

2017

  1. November 20, 2017 · Class II · Terminated · D-0101-2018 · Paroxetine

    Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets

    Paroxetine Tablets USP, 30 mg, a) 30 count (NDC 68382-099-06), b) 500 count (NDC 68382-099-05), and c) 1000 count (NDC 68382-099-10) count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distri

  2. August 18, 2017 · Class II · Terminated · D-1137-2017 · Paroxetine

    Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets

    Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, NDC 68382-099-06, UPC 3 6838209906

  3. March 6, 2017 · Class II · Terminated · D-0605-2017 · Atenolol

    Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

    ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceutica

2016

  1. November 2, 2016 · Class III · Terminated · D-0207-2017 · Bupropion

    Failed Dissolution Specifications; 6 month time point

    BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, Rx Only, a) 30 count bottles (NDC 68382-354-06) and b) 500 count bottles (NDC 68382-354-05), Manufactured by: Cadila Healthcare LTD. Ahmedabad, India Distrib

  2. August 3, 2016 · Class III · Terminated · D-0149-2017 · Bupropion

    Failed Dissolution Specifications: Product did not meet dissolution specification at an intermediate time point.

    BuPROPion Hydrochloride Extended-Release Tablets, USP (XL) 300 mg, Rx Only, 500-count bottles, Manufactured by Cadila Healthcare Ltd. Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA inc. Pennington, NJ 08534,

  3. July 19, 2016 · Class II · Terminated · D-1460-2016 · Venlafaxine

    Failed Dissolution Specifications: out of specification dissolution results in retained samples

    Venlafaxine HCL ER Capsule USP, 150mg, packaged in a) 30-count bottles (NDC 68382-036-06), b) 90-count bottles (NDC 68382-036-16), and c) 1000-count bottles, (NDC 68382-036-10), Rx only, Manufactured by : Cadila Healthca

  4. July 19, 2016 · Class II · Terminated · D-1461-2016 · Venlafaxine

    Failed Dissolution Specifications: out of specification dissolution results in retained samples

    Venlafaxine HCL ER Capsule USP, 75mg, packaged in a) 30-count bottles (NDC 68382-035-06), b) 90-count bottles (NDC 68382-035-16), and c) 1000-count bottles, (NDC 68382-035-10), Rx only, Manufactured by : Cadila Healthcar

  5. May 9, 2016 · Class II · Terminated · D-1491-2016 · Bromocriptine mesylate

    Failed impurities/degradation specifications: Out of specification results noticed in related substance test during analysis of 24 months long term (25 degree Celsius /65% RH) stability samples of two batches.

    Bromocriptine Mesylate Capsules USP, 5 mg, 30-count bottles, Rx only, Manufactured by: Cadila Healthcare ltd., Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534, NDC 68382-110-06

Showing the newest 60 of 66.

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →